Bellerophon Therapeutics CEO Fabian Tenenbaum's 2018 pay jumps 286% to $2.3M
Bellerophon Therapeutics reports 2018 executive compensation
By ExecPay News
Published: March 28, 2019
Bellerophon Therapeutics reported fiscal year 2018 executive compensation information on March 28, 2019.
In 2018, three executives at Bellerophon Therapeutics received on average a compensation package of $1.2M, a 145% increase compared to previous year.
Average pay of disclosed executives at Bellerophon Therapeutics
Fabian Tenenbaum, Chief Executive Officer, received $2.3M in total, which increased by 286% compared to 2017. 72% of Tenenbaum's compensation, or $1.7M, was in option awards. Tenenbaum also received $240K in bonus, $401K in salary, as well as $17K in other compensation.
Peter Fernandes, Chief Regulatory and Safety Officer, received a compensation package of $693K, which increased by 53% compared to previous year. 47% of the compensation package, or $323K, was in salary.
Assaf Korner, Chief Financial Officer, earned $607K in 2018.
Related executives
You may also like
Source: SEC filing on March 28, 2019.